Meilleure Health International Industry Group Limited (MEILLEUREHEALTH) has convened a Special General Meeting (SGM) for 21 April 2026, 11:00 a.m., at Portion 2, 12/F., The Center, 99 Queen’s Road Central, Hong Kong. Shareholders on record as of the same date are entitled to vote; the register of members will be closed from 16 April 2026 to 21 April 2026.

Key resolutions to be tabled:

1. Equity Interest Transfer Agreement • Directors seek ratification of an Equity Interest Transfer Agreement entered into with the vendors. • Authorisation is requested for any director to execute documents and take actions necessary to complete the transaction.

2. 2026 Share Award Scheme • Conditional on Stock Exchange approval for listing and dealing in new shares, the company proposes a new share award plan covering eligible participants. • Aggregate issuance under this scheme, together with options or awards outstanding under other share schemes, will be capped at 10% of the company’s issued share capital on the effective date. • Directors will be empowered to administer, amend and secure regulatory approvals for the scheme.

3. 1% Service Provider Sublimit • Subject to the adoption of the 2026 Share Award Scheme, a separate 1% share issuance sublimit for service providers will be introduced. • Directors will be authorised to implement and manage this sublimit.

All resolutions will be decided by poll. Proxy forms must be lodged with Tricor Investor Services Limited, 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, at least 48 hours before the SGM. Completion of a proxy form does not preclude shareholders from attending and voting in person.

As of the notice date (27 March 2026), the Board comprises three executive directors, one non-executive director and three independent non-executive directors.